Francisco Casas-Maldonado
Overview
Explore the profile of Francisco Casas-Maldonado including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alvarez-Gutierrez F, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, Gonzalez-Barcala F, Carretero-Gracia J, et al.
Arch Bronconeumol
. 2022 Oct;
59(3):190-192.
PMID: 36243640
No abstract available.
12.
Torres-Duran M, Lopez-Campos J, Rodriguez-Hermosa J, Esquinas C, Martinez-Gonzalez C, Hernandez-Perez J, et al.
ERJ Open Res
. 2022 Sep;
8(3).
PMID: 36171983
Background: The Spanish registry of α-antitrypsin deficiency (AATD) integrated in the European Alpha-1 Research Collaboration (EARCO) provides information about the characteristics of patients, in particular those with the PI*SZ genotype,...
13.
Navas-Bueno B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, Arenas-Gordillo M, Bioque-Rivera J, et al.
Arch Bronconeumol
. 2022 May;
58(12):834-836.
PMID: 35618581
No abstract available.
14.
Casas-Maldonado F, Alvarez-Gutierrez F, Blanco-Aparicio M, Domingo-Ribas C, Cisneros-Serrano C, Soto-Campos G, et al.
J Asthma
. 2021 Sep;
59(10):1997-2007.
PMID: 34503370
Background: Monoclonal antibodies (mABs) have become available to treat more efficiently patients with severe uncontrolled asthma (SUA). However, the use of mABs is lower than expected given the prevalence of...
15.
Jardim J, Casas-Maldonado F, Fernandes F, Castellano M, Torres-Duran M, Miravitlles M
J Bras Pneumol
. 2021 Jun;
47(3):e20200380.
PMID: 34076174
Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disorder caused by a mutation in the SERPINA1 gene, which encodes the protease inhibitor alpha-1 antitrypsin (AAT). Severe AATD predisposes individuals to...
16.
Miravitlles M, Nunez A, Torres-Duran M, Casas-Maldonado F, Rodriguez-Hermosa J, Lopez-Campos J, et al.
COPD
. 2020 Aug;
17(4):346-354.
PMID: 32791925
Alpha-1 antitrypsin deficiency (AATD) is a rare and underdiagnosed disease that is associated with the development of liver disease in adults and children and pulmonary emphysema in adults. Several studies...
17.
Blanco I, Diego I, Bueno P, Perez-Holanda S, Casas-Maldonado F, Miravitlles M
Eur Respir Rev
. 2020 Jul;
29(157).
PMID: 32699024
The percentage of α-antitrypsin protease inhibitor ZZ (PiZZ) genotypes in patients with COPD is controversial, with large differences among various studies. We aimed to estimate the prevalence of PiZZ in...
18.
Lopez-Campos J, Casas-Maldonado F, Torres-Duran M, Medina-Gonzalvez A, Rodriguez-Fidalgo M, Carrascosa I, et al.
Arch Bronconeumol (Engl Ed)
. 2020 Jul;
57(1):42-50.
PMID: 32680720
Introduction: The objective of this analysis was the evaluation of a new national circuit used for diagnosing alpha1 antitrypsin deficiency (AATD) based on multiplex technology using online registration and mail...
19.
Barrecheguren M, Torres-Duran M, Casas-Maldonado F, Miravitlles M
Arch Bronconeumol (Engl Ed)
. 2020 Mar;
57(2):81-82.
PMID: 32197815
No abstract available.
20.
Blanco I, Diego I, Bueno P, Casas-Maldonado F, Miravitlles M
Eur Respir J
. 2019 Apr;
54(1).
PMID: 31000678
No abstract available.